212 related articles for article (PubMed ID: 16040396)
1. Therapeutic potential of CD4+ CD25+ regulatory T cells in allogeneic transplantation.
Cohen JL; Salomon BL
Cytotherapy; 2005; 7(2):166-70. PubMed ID: 16040396
[TBL] [Abstract][Full Text] [Related]
2. CD4+CD25+ regulatory T cells and graft-versus-host disease.
Hoffmann P; Edinger M
Semin Hematol; 2006 Jan; 43(1):62-9. PubMed ID: 16412790
[TBL] [Abstract][Full Text] [Related]
3. Numbers of Foxp3-expressing CD4+CD25high T cells do not correlate with the establishment of long-term tolerance after allogeneic stem cell transplantation.
Meignin V; Peffault de Latour R; Zuber J; Régnault A; Mounier N; Lemaître F; Dastot H; Itzykson R; Devergie A; Cumano A; Gluckman E; Janin A; Bandeira A; Socié G
Exp Hematol; 2005 Aug; 33(8):894-900. PubMed ID: 16038781
[TBL] [Abstract][Full Text] [Related]
4. [CD4+, CD25+ regulatory T-lymphocytes: current concepts and therapeutic potential].
Salomon B
J Soc Biol; 2002; 196(4):263-6. PubMed ID: 12645292
[TBL] [Abstract][Full Text] [Related]
5. Ex vivo selection of recipient-type alloantigen-specific CD4(+)CD25(+) immunoregulatory T cells for the control of graft-versus-host disease after allogeneic hematopoietic stem-cell transplantation.
Trenado A; Fisson S; Braunberger E; Klatzmann D; Salomon BL; Cohen JL
Transplantation; 2004 Jan; 77(1 Suppl):S32-4. PubMed ID: 14726768
[TBL] [Abstract][Full Text] [Related]
6. Immune regulation by CD4+CD25+ regulatory T cells: implications for transplantation tolerance.
Taams L; Vukmanovic-Stejic M; Salmon M; Akbar A
Transpl Immunol; 2003; 11(3-4):277-85. PubMed ID: 12967781
[TBL] [Abstract][Full Text] [Related]
7. Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia.
Trenado A; Charlotte F; Fisson S; Yagello M; Klatzmann D; Salomon BL; Cohen JL
J Clin Invest; 2003 Dec; 112(11):1688-96. PubMed ID: 14660744
[TBL] [Abstract][Full Text] [Related]
8. CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation.
Atanackovic D; Cao Y; Luetkens T; Panse J; Faltz C; Arfsten J; Bartels K; Wolschke C; Eiermann T; Zander AR; Fehse B; Bokemeyer C; Kroger N
Haematologica; 2008 Mar; 93(3):423-30. PubMed ID: 18287134
[TBL] [Abstract][Full Text] [Related]
9. Vasoactive intestinal peptide generates CD4+CD25+ regulatory T cells in vivo.
Delgado M; Chorny A; Gonzalez-Rey E; Ganea D
J Leukoc Biol; 2005 Dec; 78(6):1327-38. PubMed ID: 16204628
[TBL] [Abstract][Full Text] [Related]
10. CD25 expression distinguishes functionally distinct alloreactive CD4 CD134 (OX40) T-cell subsets in acute graft-versus-host disease.
Streeter PR; Zhang X; Tittle TV; Schön CN; Weinberg AD; Maziarz RT
Biol Blood Marrow Transplant; 2004 May; 10(5):298-309. PubMed ID: 15111929
[TBL] [Abstract][Full Text] [Related]
11. Induction of transplantation tolerance by allogeneic donor-derived CD4(+)CD25(+)Foxp3(+) regulatory T cells.
Velásquez-Lopera MM; Eaton VL; Lerret NM; Correa LA; Decresce RP; García LF; Jaramillo A
Transpl Immunol; 2008 May; 19(2):127-35. PubMed ID: 18503888
[TBL] [Abstract][Full Text] [Related]
12. The role of CD4+CD25hi regulatory T cells in the physiopathogeny of graft-versus-host disease.
Cohen JL; Boyer O
Curr Opin Immunol; 2006 Oct; 18(5):580-5. PubMed ID: 16879951
[TBL] [Abstract][Full Text] [Related]
13. CD4+CD25+ regulatory T cells in human hematopoietic cell transplantation.
Zorn E
Semin Cancer Biol; 2006 Apr; 16(2):150-9. PubMed ID: 16431128
[TBL] [Abstract][Full Text] [Related]
14. CD4+CD25+ regulatory T cells mediate acquired transplant tolerance.
Oluwole SF; Oluwole OO; DePaz HA; Adeyeri AO; Witkowski P; Hardy MA
Transpl Immunol; 2003; 11(3-4):287-93. PubMed ID: 12967782
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow-derived mesenchymal stem cells decrease acute graft-versus-host disease after allogeneic hematopoietic stem cells transplantation.
Tian Y; Deng YB; Huang YJ; Wang Y
Immunol Invest; 2008; 37(1):29-42. PubMed ID: 18214798
[TBL] [Abstract][Full Text] [Related]
16. Role of naturally arising regulatory T cells in hematopoietic cell transplantation.
Nguyen VH; Zeiser R; Negrin RS
Biol Blood Marrow Transplant; 2006 Oct; 12(10):995-1009. PubMed ID: 17084366
[TBL] [Abstract][Full Text] [Related]
17. Depletion of alloreactive T cells via CD69: implications on antiviral, antileukemic and immunoregulatory T lymphocytes.
Hartwig UF; Nonn M; Khan S; Meyer RG; Huber C; Herr W
Bone Marrow Transplant; 2006 Feb; 37(3):297-305. PubMed ID: 16327814
[TBL] [Abstract][Full Text] [Related]
18. The cellular basis of cardiac allograft rejection. IX. Ratio of naïve CD4+CD25+ T cells/CD4+CD25- T cells determines rejection or tolerance.
Nomura M; Plain KM; Verma N; Robinson C; Boyd R; Hodgkinson SJ; Hall BM
Transpl Immunol; 2006 Apr; 15(4):311-8. PubMed ID: 16635754
[TBL] [Abstract][Full Text] [Related]
19. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
20. Dendritic cells expand antigen-specific Foxp3+ CD25+ CD4+ regulatory T cells including suppressors of alloreactivity.
Yamazaki S; Inaba K; Tarbell KV; Steinman RM
Immunol Rev; 2006 Aug; 212():314-29. PubMed ID: 16903923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
